Abstract
Introduction: Despite the successful implementation of Haemophilus influenzae vaccination, invasive serotypes still lead to a fatal infection. We recently cared for a patient with a ventriculoperitoneal shunt (VPS) and H. influenzae meningitis and septicemia complicated by vasospasm. Vasospasm caused by Haemophilus central nervous system infection has not been previously reported. Case Presentation: A 34-month-old patient with a recent VPS presented with H. influenzae meningitis and sepsis. Despite the explant of hardware, followed by maximum medical management, the patient developed stroke due to severe vasospasm, which led to diffused anoxic brain injury. Conclusions: We aim to alert for the possible critical condition caused by H. influenzae. It is essential to treat the underlying illness, despite the presence of a VPS. Surgical implant tends to be overlooked by other subspecialists. Being vaccinated to H. influenzae does not protect from different subtypes like non-typeable H. influenzae. The cause of vasospasm remains unclear.
References
1.
Falla
TJ
, Dobson
SR
, Crook
DW
, Kraak
WA
, Nichols
WW
, Anderson
EC
, et al. Population-based study of non-typable Haemophilus influenzae invasive disease in children and neonates
. Lancet
. 1993 Apr 3
;341
(8849
):851
–4
. .2.
Kay
SE
, Nack
Z
, Jenner
BM
. Meningitis and septicaemia in a child caused by non-typable Haemophilus influenzae biotype III
. Med J Aust
. 2001 Nov 5
;175
(9
):484
–5
. .3.
Wong
GW
, Oppenheimer
SJ
, Vaudry
W
. CSF shunt infection by unencapsulated Haemophilus influenzae
. Clin Infect Dis
. 1993 Sep
;17
(3
):519
–20
. .4.
Albright
ALP
, Ian
F
, Adelson
PD
. Principles and practice of pediatric neurosurgery third edition 77: shunt infection: 1010–1022
. New York
: Thime
; 2015
.5.
Shuel
M
, Hoang
L
, Law
DK
, Tsang
R
. Invasive Haemophilus influenzae in British Columbia: non-Hib and non-typeable strains causing disease in children and adults
. Int J Infect Dis
. 2011 Mar
;15
(3
):e167
–73
. .6.
Collins
S
, Litt
DJ
, Flynn
S
, Ramsay
ME
, Slack
MP
, Ladhani
SN
. Neonatal invasive Haemophilus influenzae disease in England and Wales: epidemiology, clinical characteristics, and outcome
. Clin Infect Dis
. 2015 Jun 15
;60
(12
):1786
–92
. .7.
Eton
V
, Schroeter
A
, Kelly
L
, Kirlew
M
, Tsang
RSW
, Ulanova
M
. Epidemiology of invasive pneumococcal and Haemophilus influenzae diseases in Northwestern Ontario, Canada, 2010–2015
. Int J Infect Dis
. 2017 Dec
;65
:27
–33
. .8.
Chiappini
E
, Inturrisi
F
, Orlandini
E
, de Martino
M
, de Waure
C
. Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000–2016 period
. BMC Infect Dis
. 2018 Aug 13
;18
(1
):396
. .9.
Soeters
HM
, Blain
A
, Pondo
T
, Doman
B
, Farley
MM
, Harrison
LH
, et al. Current epidemiology and trends in invasive Haemophilus influenzae disease-United States, 2009–2015
. Clin Infect Dis
. 2018 Aug 31
;67
(6
):881
–9
. .10.
Deininger
MH
, Berlis
A
, Buttler
J
. Cerebral vasospasm in shunt infection
. Neurocrit Care
. 2007
;7
(1
):27
–30
. .11.
Swartz
MN
. Bacterial meningitis: more involved than just the meninges
. N Engl J Med
. 1984 Oct 4
;311
(14
):912
–4
. .12.
Ries
S
, Schminke
U
, Fassbender
K
, Daffertshofer
M
, Steinke
W
, Hennerici
M
. Cerebrovascular involvement in the acute phase of bacterial meningitis
. J Neurol
. 1997 Jan
;244
(1
):51
–5
. .13.
Ballabh
P
, Braun
A
, Nedergaard
M
. The blood-brain barrier: an overview: structure, regulation, and clinical implications
. Neurobiol Dis
. 2004 Jun
;16
(1
):1
–13
. .14.
Hauser
S
, Wegele
C
, Stump-Guthier
C
, Borkowski
J
, Weiss
C
, Rohde
M
, et al. Capsule and fimbriae modulate the invasion of Haemophilus influenzae in a human blood-cerebrospinal fluid barrier model
. Int J Med Microbiol
. 2018 Oct
;308
(7
):829
–39
.15.
Taccone
FS
, Scolletta
S
, Franchi
F
, Donadello
K
, Oddo
M
. Brain perfusion in sepsis
. Curr Vasc Pharmacol
. 2013 Mar 1
;11
(2
):170
–86
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
